Generalized fixed drug eruption to piperacillin/tazobactam and review of literature

Heather Kornmehl, Farzam Gorouhi, Thomas Konia, Maxwell A Fung, Danielle Tartar

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces. The reaction occurs on the same mucosal or cutaneous site with subsequent exposures to the offending drug. Although FDE usually manifests as a single lesion, in rare instances, more than one lesion may arise and this is referred to as a generalized eruption. Herein, we present a 31year-old man with history of cystic fibrosis who developed a generalized fixed drug eruption to piperacillin/tazobactam (Zosyn, Pfizer). We discuss our patient’s course and review causes and outcomes of generalized fixed drug eruptions in the literature.

Original languageEnglish (US)
Article number14
JournalDermatology Online Journal
Volume24
Issue number4
StatePublished - Apr 1 2018

Fingerprint

Drug Eruptions
Skin
Drug-Related Side Effects and Adverse Reactions
Cystic Fibrosis
tazobactam drug combination piperacillin
Pharmaceutical Preparations

Keywords

  • Fixed drug eruption
  • Generalized fixed drug eruption
  • Piperacillin/tazobactam

ASJC Scopus subject areas

  • Dermatology

Cite this

Generalized fixed drug eruption to piperacillin/tazobactam and review of literature. / Kornmehl, Heather; Gorouhi, Farzam; Konia, Thomas; Fung, Maxwell A; Tartar, Danielle.

In: Dermatology Online Journal, Vol. 24, No. 4, 14, 01.04.2018.

Research output: Contribution to journalArticle

@article{1c16be8aad0b4cf09fd168ea34e2a047,
title = "Generalized fixed drug eruption to piperacillin/tazobactam and review of literature",
abstract = "Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces. The reaction occurs on the same mucosal or cutaneous site with subsequent exposures to the offending drug. Although FDE usually manifests as a single lesion, in rare instances, more than one lesion may arise and this is referred to as a generalized eruption. Herein, we present a 31year-old man with history of cystic fibrosis who developed a generalized fixed drug eruption to piperacillin/tazobactam (Zosyn, Pfizer). We discuss our patient’s course and review causes and outcomes of generalized fixed drug eruptions in the literature.",
keywords = "Fixed drug eruption, Generalized fixed drug eruption, Piperacillin/tazobactam",
author = "Heather Kornmehl and Farzam Gorouhi and Thomas Konia and Fung, {Maxwell A} and Danielle Tartar",
year = "2018",
month = "4",
day = "1",
language = "English (US)",
volume = "24",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "4",

}

TY - JOUR

T1 - Generalized fixed drug eruption to piperacillin/tazobactam and review of literature

AU - Kornmehl, Heather

AU - Gorouhi, Farzam

AU - Konia, Thomas

AU - Fung, Maxwell A

AU - Tartar, Danielle

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces. The reaction occurs on the same mucosal or cutaneous site with subsequent exposures to the offending drug. Although FDE usually manifests as a single lesion, in rare instances, more than one lesion may arise and this is referred to as a generalized eruption. Herein, we present a 31year-old man with history of cystic fibrosis who developed a generalized fixed drug eruption to piperacillin/tazobactam (Zosyn, Pfizer). We discuss our patient’s course and review causes and outcomes of generalized fixed drug eruptions in the literature.

AB - Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces. The reaction occurs on the same mucosal or cutaneous site with subsequent exposures to the offending drug. Although FDE usually manifests as a single lesion, in rare instances, more than one lesion may arise and this is referred to as a generalized eruption. Herein, we present a 31year-old man with history of cystic fibrosis who developed a generalized fixed drug eruption to piperacillin/tazobactam (Zosyn, Pfizer). We discuss our patient’s course and review causes and outcomes of generalized fixed drug eruptions in the literature.

KW - Fixed drug eruption

KW - Generalized fixed drug eruption

KW - Piperacillin/tazobactam

UR - http://www.scopus.com/inward/record.url?scp=85048708566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048708566&partnerID=8YFLogxK

M3 - Article

C2 - 29906010

AN - SCOPUS:85048708566

VL - 24

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 4

M1 - 14

ER -